business

Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid

Yahoo Finance · Jun 9, 2026, 1:21 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Bloomberg Markets GSK Agrees to Buy Nuvalent for $10.6 Billion Investing.com UK’s GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion DW English World conflicts hit record high in 2025: report Al Jazeera Nuclear weapons spending surges to record high of $119bn, report says

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid

Also covered by

More in business